Global Market Insights, Inc.

2019 Industry Insights Breast Cancer Therapeutics Market: Key Players: Eli Lilly and Company, Sanofi, AstraZeneca, Eisai US

Breast Cancer Therapeutics Market to Exceed $28Bn by 2024


Sellbyville, DE -- (SBWIRE) -- 01/16/2019 -- Global Breast Cancer Therapeutics Market set to exceed USD 28 billion by 2024; according to a new research report by Global Market Insights, Inc.

U.S. breast cancer therapeutics market accounted for largest business share in 2016 and is anticipated to grow substantially over the forecast period. Increases access to breast cancer screening, diagnosis and treatment services will be the chief growth rendering factor. Moreover, increasing adoption of therapy drug by patients will fuel regional business growth. Rising incidence of disease due to increasing exposure to factors such as use of hormone replacement therapy (HRT), lifestyle related factors such as alcohol consumption, obesity and alteration in family size which stimulates the usage rate of therapeutics over the forecast period will propel the industry growth.

Request for a sample of this research report @

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
- Teva Pharmaceuticals
- Pfizer
- Novartis
- Sanofi
- AstraZeneca
- Eisai US
- Eli Lilly and Company
- Roche Diagnostics Middle East
- Celgene

Targeted drug therapy market accounted for largest market share in 2016 and is forecast to witness substantial growth over the coming years owing to associated factors like targeting certain parts of tumor cells that allow the tumor cells to grow faster and abnormally, resulting in turn off or blockage of chemical signals. Furthermore, features such as stopping growth of new blood vessels, changing proteins, triggering immune system, and carrying toxins to the tumor cells to kill cells will drive the therapy demand over forecast years.

Retail pharmacies held the largest market share in 2016 and will continue to be the biggest distribution channel for the industry over the forecast period. Growing shift from specialty to retail pharmacies owing to reimbursement variations and prolonged usage of oral formulations, particularly for targeted drug therapies will drive the business growth.

Make an inquiry for purchasing this report @

Moreover, growing number of retail store and augmented investment in retail stores by retail giants in developing as well as developed economies will further boost the industry share. Hospitals segment will grow at a considerable rate in the coming year pertaining to administration of drugs available in injectable forms in hospital settings which are reimbursed by patient's medical benefits.

Breast Cancer Therapeutics market by product
o Hormone Drugs
o Chemotherapy Drugs
o Targeted Drug Therapy

Breast Cancer Therapeutics market by distribution channel
o Hospitals
o Ambulatory Surgical Centers
o Clinics
o e-Commerce
o Retail Pharmacies